Health Canada
- Status: approved
Recombinant human brain natriuretic peptide (Recombinant human brain natriuretic peptide) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Shanghai Zhongshan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.